Now that vaccines protecting people from the corona virus have arrived, the danger of dangerous attacks of anaphylaxis have arrived as well. Proper administration of epinephrine is now almost as important as using the vaccine itself. Our association fully supports comprehensive training on how to use an epinephrine auto-injector (EAI) device in an anaphylaxis emergency.
By Robert K. Houton
The COVID-19 vaccination that began rolling out this week to frontline medical workers will hopefully end our long nightmare with this virus and the pandemic. But there is one concern: 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine.
As a result, all sites that are injecting the Pfizer-BioNTech COVID-19 vaccine are required to have epinephrine auto-injector devices (Epi-Pens) as a safety precaution if an allergic reaction, occurs after the vaccine is given. Epinephrine, also known as adrenaline, is the only medication recommended as a first-treatment medicine in reversing the life-threatening reaction in an anaphylactic attack.